Dr. Barry Dworkin

Logistics of distributing mRNA vaccines (if approved) will be problematic. Excellent article in @TheAtlantic explains why.

Medical Mythbusting Commentary for October 5, 2020

Source:
Vaccine Chaos Is Looming

Related posts:

  1. Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
  2. New research and development on needleless vaccine delivery systems shows promise but human trials required
  3. New biotherapeutic cancer treatment centre an excellent addition to novel therapeutic solutions
  4. The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.